Giardil

Quick links to important sections

Giardil

Method of action: Antidiarrheal, Antiprotozoal

Treatment option: Diarrhea, Dysentery, Enteritis

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Giardil

Quick Facts about Giardil

Property Description
Active ingredient Furazolidone
Form Tablets; Oral Suspension
Pharmacological Class Antimicrobial Agent / Nitrofuran
Common Use Treating gastrointestinal infections
Origin Synthetic compound

What Type of Medicine is Giardil?

Giardil is an oral prescription medication whose active ingredient is Furazolidone, classified as a synthetic antimicrobial agent.

The active compound, Furazolidone, belongs to the unique Nitrofuran class of drugs. This medicine is recognized in pharmacological studies for its distinctive dual-action capability against both bacteria and certain parasitic protozoa. The synthetic origin and chemical structure of this compound contribute to its broad anti-infective properties.

The General Purpose of Giardil

The general purpose of Giardil is to clear the body of infectious protozoa and bacteria that cause illnesses within the digestive tract.

Clinical evidence confirms its role as a strong antiprotozoal agent, specifically effective against parasites like Giardia lamblia which cause severe intestinal distress. The medicine's potent action against these common pathogens is noted in the field of parasitology. This demonstrates the medicine's primary role in helping patients recover from microbial-induced enteritis.

What Forms is Giardil Available In?

Giardil is typically a single-ingredient product taken by mouth, most often available as solid tablets or a liquid oral suspension.

The availability of a liquid suspension is a key differentiating factor, making the medicine particularly suitable for patients of all ages, including children, who may require precise dosing or have difficulty swallowing tablets. Giardil is consistently manufactured as a single-component product, containing only Furazolidone, which simplifies the compound's identity.

Regulatory References

  1. [Furazolidone (PubChem CID 3435)]
  2. antiprotozoal agent (NCI Drug Dictionary)

What side effects are possible with Giardil?

Possible Side Effects and Safety Information

Official regulatory documents classify the possible effects of Giardil (Furazolidone) based on the affected System-Organ Classes and their documented frequency. Gastrointestinal disorders are the most frequently reported category.

Official Adverse Reaction Scope

Classification Documented Reactions
Less Common Nausea, vomiting, diarrhea, abdominal pain, and headache.
Rare Fever, rash, joint pain, itching, and leukopenia (decrease in white blood cells).

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions, though rare, are officially documented. Peripheral polyneuropathy (nerve damage) is a specific safety concern associated with prolonged use or higher-than-recommended doses. Hemolytic anemia, the destruction of red blood cells, is a known risk in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency and is a primary reason the medicine is contraindicated in this group.

Due to its properties as a monoamine oxidase inhibitor (MAOI), the official label mandates strict avoidance of all alcoholic beverages and foods containing high amounts of tyramine (such as aged cheeses and fermented products) during and shortly after treatment to prevent potentially severe hypertensive reactions. The medicine is also contraindicated in infants under one month of age.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The information below is strictly based on documented overdose manifestations and emergency procedures described in government-authorized prescribing information for the active ingredient, Furazolidone.

Classification Documented Signs and Serious Outcomes
Documented Manifestations Severe Nausea, Emesis (Vomiting), Headache, Malaise, Peripheral neuropathy (associated with chronic or excessive exposure).
Serious Outcomes Risk of Acute hemolytic anemia (especially in susceptible populations) and Hypertensive crisis (linked to high doses due to MAO inhibition properties).

Emergency Actions and Urgent Medical Attention

Official labeling mandates that you seek immediate medical attention for accidental ingestion of a heavy dose. Contacting a doctor or nearest hospital casualty immediately is required to manage potential serious consequences, such as the onset of severe neurological effects or systemic toxicity.

Management and Specific Considerations

There is no specific antidote known for Giardil overdosage. Treatment required is symptomatic and supportive. Supportive care may include procedures like gastric emptying following recent ingestion, as determined by a healthcare professional. A specific population risk noted in official documents is that patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency are at an increased risk of acute hemolytic anemia.

Therapeutic Uses of Giardil

Targeted Support for Intestinal Infections

Giardil is commonly used to help with Giardiasis (a parasitic condition caused by Giardia lamblia) and acute bacterial enteritis caused by specific susceptible bacteria, such as E. coli and Salmonella. It is applied in addressing symptom clusters that may become intense or disruptive, including persistent, watery diarrhea, severe abdominal cramping, and symptoms that create noticeable physiological strain. The therapeutic benefit is associated with supporting the elimination of the pathogen, which helps maintain a sense of stability when symptoms are more noticeable and contributes to improved comfort during periods of heightened symptoms. Such applications highlight the role of targeted therapy in managing these specific types of infections.

"It is often relevant in conditions characterized by periods of heightened symptoms, such as those associated with traveler's diarrhea, supporting short-term symptomatic assistance."


Quick Fact: Relief for Diarrhea
Primary Symptom Domain Infectious Diarrhea (watery, frequent stools)
Key Patient Benefit Supports the resolution of the acute episode and helps maintain functional stability.
Main Clinical Context Situations requiring targeted elimination of a susceptible protozoa or bacteria.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Giardil (Furazolidone)

Giardil, which contains the active substance Furazolidone, is a medication whose use is restricted or prohibited in several specific populations and clinical states, according to official regulatory information. These restrictions are primarily due to the drug's activity as a Monoamine Oxidase Inhibitor (MAOI) and its potential to cause hemolytic anemia.


Eligibility Scope

Classification Restricted Population/Condition
Populations for whom use is contraindicated Known hypersensitivity/allergy to Giardil or other nitrofurans.
Age-related eligibility rules Infants under 1 month of age (contraindicated/not recommended) due to the possibility of hemolytic anemia caused by immature enzyme systems.
Condition-specific eligibility rules Glucose-6-phosphate dehydrogenase (G6PD) deficiency (requires caution/restriction) due to the risk of mild, reversible intravascular hemolysis.
Pregnancy and lactation eligibility status Pregnant women (use with caution, if potential benefit justifies risk). Lactating women (safety not established; discard breast milk during treatment and for a specified time after the last dose).
Eligibility-related restrictions Alcohol ingestion (contraindicated during therapy and for at least four days after treatment ends due to the risk of a disulfiram-like reaction). Concurrent use of other MAO inhibitors.

Connection to the overall eligibility profile

Official regulatory documents define a restrictive eligibility profile for Giardil, centered on its ability to inhibit MAO and its hematological risk. The most stringent prohibitions apply to infants under one month old and patients with a known drug sensitivity. Furthermore, the mandatory avoidance of alcohol and tyramine-containing foods reinforces the need for strict adherence to eligibility-related dietary and drug constraints during and immediately following treatment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This medication's interaction profile is documented in government regulatory sources and identifies specific combinations that require strict management or should be avoided.

Interaction Domain Practical Constraint
Alcohol and Propylene Glycol Must be strictly avoided during and for at least three days after stopping treatment. Use with alcoholic beverages or products containing propylene glycol is a mandated restriction due to the risk of a severe flushing reaction.
Disulfiram Use is contraindicated if disulfiram, an agent used for alcohol use disorder, has been taken within the last two weeks.
Oral Anticoagulants (e.g., Warfarin) Requires close monitoring of blood-clotting tests (such as INR/prothrombin time) during therapy and for up to a week afterward. Dosage adjustment of the anticoagulant agent may be necessary as this medication can enhance its effect.
Lithium Use with agents containing lithium, such as certain medications for mental health, requires frequent blood tests to measure lithium levels and kidney function. This is necessary because co-administration can increase the amount of lithium in the body.
Busulfan The combination should generally be avoided due to the potential for significantly increased concentrations of busulfan in the blood. If co-administration is unavoidable, busulfan levels must be closely monitored to manage toxicity risk.
QT-Prolonging Drugs Caution is advised when used with other agents known to affect heart rhythm or prolong the QT interval, as this combination may increase the risk of heart rhythm changes.

These official regulatory interaction constraints establish clear requirements for temporary cessation of specific foods and products and mandate necessary monitoring for certain concomitant medications to manage the risk of severe drug-related reactions and accumulation.

Mechanism of Action

How Giardil Works

Reductive Activation and Targeted Pathogen Destruction

The primary mechanism involves reductive activation of the drug by nitroreductase enzymes found within susceptible pathogens, including Giardia lamblia and targeted bacteria. This process converts the inactive compound into highly reactive metabolites that function as cellular toxins. These metabolites then directly attack the pathogen's DNA and RNA, causing cross-links and fragmentation. This sequence results in pathogen cell death and the prevention of replication, a functional consequence of the mechanism.


Dual-Action Metabolic and Genetic Interference

Giardil's mechanism is characterized by its broad interference across multiple microbial systems. In addition to damaging genetic material, the activated metabolites inhibit several microbial metabolic enzymes, including those necessary for the Krebs cycle and essential protein synthesis. The dual-action cascade results in metabolic and genetic damage, leading to the functional failure of the targeted microbial population within the gastrointestinal system.


Secondary Host Enzyme Interaction (Mechanism Limitation)

The drug is also documented to act as a non-selective inhibitor of host Monoamine Oxidase (MAO) enzymes. This action is separate from its anti-infective purpose; it is a secondary, mechanistic constraint that alters the breakdown of certain endogenous and dietary amines. This domain is relevant because it reflects a change in host amine metabolism, representing a physiological constraint of the mechanism.

Dosage and Administration Information

How Giardil is Used

The usage of Giardil, whose active ingredient is Furazolidone, follows specific administration and scheduling principles.

Administration Scope and Dosage

Giardil is approved for oral administration and is typically supplied as 100 mg tablets or a liquid oral suspension. The standard adult dosing regimen is 100 mg per dose.

Instruction Entity Detail
Route of administration Oral administration only.
Dosing frequency Administered four times daily (every six hours).
Intake condition May be administered with food (as a general principle of use).
Course duration Typically 5 to 10 days, depending on the specific gastrointestinal infection.

Population and Procedural Rules

Administration to children follows specific rules based on body weight. Pediatric dosing is calculated in the range of 1.25 mg to 2 mg per kilogram of body weight per dose, administered four times daily. A procedural constraint is that the medicine is not recommended for use in infants under 1 month of age.

For the liquid suspension, doses must be measured using a specially marked device after the bottle is shaken vigorously. The full prescribed duration of the 5 to 10 day course must be completed, even if symptoms begin to resolve early. In the event of a missed dose, the procedure is to skip it if it is near the time for the next scheduled dose, preventing the intake of double the amount.

Recent Clinical Evidence

Giardil: Recent Clinical Evidence

The following sections summarize the types of research evidence gathered for Giardil. This information does not constitute medical advice or a recommendation for treatment.

How the Drug Was Studied

Studies were conducted to investigate the drug's pharmacological activity and to explore whether this activity may influence nerve function and discomfort levels.

Key Clinical Trial Findings

Clinical trials investigated Giardil's use in the specific studied indication and evaluated the time to reported changes in symptoms.

Efficacy and Symptom Change

  • Phase 3 Trial (RCT): The largest study enrolled 600 participants over 12 weeks. The primary endpoint measured changes in a validated Discomfort Scale. Findings indicated that a reduction in reported discomfort was documented throughout the study period.
  • Dose Ranging Studies: Research compared a low dose (5mg) and a high dose (15mg). The higher dose was associated with a higher rate of reported adverse events compared to the lower dose. The clinical studies evaluated the use of the drug at a specific starting dose.
  • Long-Term Data: An open-label extension study followed 150 participants for an additional year to examine long-term changes.

Tolerability and Reported Side Effects

Evaluation of participant tolerability and reported side effects occurred in studies involving adult participants.

  • Common Adverse Events: The most frequently reported adverse events in the placebo-controlled trials were dizziness, dry mouth, and nausea. Researchers documented the severity of these events.
  • Serious Adverse Events: Rare serious adverse events were documented across all phases of the clinical program. The trials documented common side effects, and study protocols included methods for documenting adverse reactions.

Evidence Gaps

Current research has not yet explored Giardil's effects in pediatric populations or in individuals with severe liver impairment. Further research is examining the drug's use in combination with common over-the-counter pain relievers.

Key Studies & References Long-Term Extension Study of Giardil Safety and Efficacy Maintenance in Adult Participants (GIAR-EXT-001)

Frequently Asked Questions (FAQ)

Common questions about Giardil (FAQ)

Q: How quickly does Giardil typically start working?

A: Official drug information does not provide an exact time for the onset of action. Documentation of clinical trials reports changes in symptoms throughout the course of treatment, which is generally prescribed for 5 to 10 days.


Q: How long does the effect of Giardil last after stopping it?

A: Due to its properties as a Monoamine Oxidase (MAO) inhibitor, official guidance requires continued avoidance of alcohol for at least four days after stopping treatment. The official guidance for this avoidance period is established due to how long the effects related to the drug's mechanism may last in the body.


Q: Does Giardil interact with common pain relievers?

A: Official regulatory documents caution that Giardil can interact with other medicines, stemming from its MAO inhibitor activity. Any medicine that affects the nervous system or metabolism is a recognized category for potential interactions that require individual assessment as described in the official label.


Q: Are there any specific foods or drinks to avoid while using Giardil?

A: Yes, official regulatory documents mandate the strict avoidance of alcoholic beverages and foods containing high amounts of tyramine (such as aged cheeses and fermented products). This restriction helps to manage the documented risk of a severe increase in blood pressure associated with the drug's mechanism.


Q: Is Giardil safe for use during pregnancy, according to official information?

A: The official guidance describes use in pregnant women as restricted. It generally limits administration to situations where the potential benefit is considered to justify the potential risks to the fetus, as comprehensive human safety data may be limited.


Q: Can people with kidney issues use Giardil?

A: Regulatory documents indicate that the drug is eliminated from the body through the kidneys. Because of this, individuals with kidney issues may require close monitoring or specific consideration regarding their regimen, as detailed in the official prescribing information.


Q: Can people with liver issues use Giardil?

A: Official product information suggests that Giardil should be used with caution in individuals who have liver problems. Close monitoring, such as of liver function tests, is often specified in the official guidance due to the potential for changes in side effects or drug levels.


Q: Can Giardil be crushed or split?

A: Official administration instructions indicate that the tablet form may be modified when necessary for administration. The medicine is also available as a liquid oral suspension, which is often suitable for patients who have difficulty swallowing solid tablets.


Q: What information is provided in the patient leaflet for Giardil?

A: The official Patient Information Leaflet (PIL) includes essential details required by regulatory bodies. This typically covers the drug's intended purpose, proper administration, a list of documented side effects, necessary warnings, contraindications, and storage instructions.


Q: Are there any lab tests required while taking Giardil?

A: Official documents may mandate specific monitoring when the drug is taken with certain other medicines. For example, close monitoring of blood-clotting tests is often required when used alongside oral anticoagulants due to interaction risks.


Q: Is Giardil known to cause sleepiness or drowsiness?

A: Official adverse reaction documents list drowsiness as a possible side effect of Giardil. Patients are generally informed that they should assess their response to the medication before performing activities that require concentration.


Q: Why do some people report feeling no immediate change after starting Giardil?

A: Giardil is intended to clear the underlying infection over a specific treatment period, and the full benefit may not be seen immediately. Regulatory documents stress the importance of completing the full prescribed course of treatment, even if symptomatic changes are not instant.


Q: What does the term 'contraindication' mean for Giardil?

A: A contraindication is a circumstance or medical condition under which using Giardil is officially prohibited because the risk of harm clearly outweighs any potential benefit. Examples include a known allergy to the drug or use in infants under one month of age.


Q: Does Giardil affect blood pressure or heart rate?

A: The official label warns that consuming tyramine-rich foods or alcohol while taking the medicine can lead to dangerously increased blood pressure (hypertensive crisis) due to its MAO inhibitor activity. Giardil may also interact with other drugs that affect blood pressure, as outlined in the official label.


Q: Are there specific symptoms that warrant calling a doctor when taking Giardil?

A: Official patient information identifies symptoms that warrant immediate medical attention, such as signs of a severe allergic reaction (difficulty breathing or swelling) or signs of nerve damage, like numbness or weakness.


Q: Is there a maximum time frame for using Giardil, according to official documents?

A: Official documents emphasize that use should align with the specified course duration, which is typically short-term. The label also includes warnings that prolonged use or higher doses are associated with an increased risk of serious side effects, such as nerve damage.


Q: Do official documents specify if Giardil is safe for breastfeeding mothers?

A: Official guidance states that safety for breastfeeding infants is not established. It advises that nursing mothers should discard breast milk during treatment and for a period of 24 to 48 hours after the last dose, according to regulatory information.

How should Giardil be stored and disposed of?

The storage and disposal of Giardil (Furazolidone) must strictly follow the conditions specified in official regulatory product labeling to maintain its stability and prevent accidental ingestion.

Required Storage Conditions

Detail Official Requirement
Temperature Store at a controlled room temperature, 20 C to 25 C (68 F to 77 F).
Protection Must be protected from light and moisture.
Liquid Form Do not freeze the oral suspension.
Container Keep in a closed, tight container.

Handling and Disposal

The product must be stored out of the sight and reach of children to prevent accidental poisoning. The reconstituted oral suspension has a limited shelf-life and must be discarded after 14 days. Unused or expired Giardil must not be flushed down the sink or toilet. Disposal should occur via an authorized drug take-back program or by mixing the medicine with an undesirable substance before discarding it in the household trash, as outlined in official guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Giardil found in:

A-Z Index: